No, Lilly is looking for a way to capitalize on a product (insulin) and cross sell different devices etc.. Lilly is NOT a device company. Lilly will end up like Animas. What Lilly should look into are medications that treat fatty liver disease! It’s always been a problem with Type 2 diabetes and those that are obese. Lilly hasn’t looked into new therapies for at least two decades! Lilly is lost when it comes to TRUE innovation!
